The Asia Pacific Metagenomics Market would witness market growth of 14.7% CAGR during the forecast period (2022-2028).
Misassembles are produced by the existence of repeating DNA sequences that make assembly particularly challenging due to the disparity in the relative number of species within the sample. Misassembles may also entail the combining of sequences from multiple species to produce chimeric contigs. There are numerous assembly programs, the majority of which can leverage information from paired-end tags to improve assembly precision.
Some tools, such as Phrap or Celera Assembler, were intended to be used to assemble single genomes, but they give satisfactory results when used to assemble metagenomic data sets. Using de Bruijn graphs, Velvet assembler and other programs have been tuned for the shorter reads generated by second-generation sequencing.
The restricted number of microbial phyla for which sequenced genomes are available restricts the utility of reference genomes for improving the assembly of the most abundant microbial species. After an assembly has been completed, another problem is "metagenomic deconvolution," or determining which sequences in the sample come from which species. Sequences must be binned to relate community makeup and function in metagenomes.
Utilizing digital healthcare technologies, China responded promptly to the coronavirus outbreak in 2019. Existing research has overlooked the formation of the COVID-19 digital health ecosystem, despite the technical analysis and discussion of genuine digital health breakthroughs. COVID-19 will capture and distribute the key reasons that contributed to China's quick deployment of digital health initiatives, as well as the lessons learned. Medical equipment is the most active and strategically significant part of the healthcare sales industry for international firms.
The China market dominated the Asia Pacific Metagenomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $198.7 Million by 2028.The Japan market is estimated to grow a CAGR of 14% during (2022 - 2028). Additionally, The India market would experience a CAGR of 15.4% during (2022 - 2028).
Based on Workflow, the market is segmented into Sequencing, Pre-sequencing and Data Analysis. Based on Product, the market is segmented into Kits & Reagents, Sequencing & Data Analytics Services and Software. Based on Technology, the market is segmented into Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing and Others. Based on Application, the market is segmented into Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & Nutrition and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Metagenomics Market is Projected to reach USD 3.2 Billion by 2028, at a CAGR of 13.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, Qiagen N.V., Takara Bio, Inc. (Takara Holdings Inc.), Oxford Expression Technologies Ltd., and F. Hoffmann-La Roche Ltd.
By Workflow
By Product
By Technology
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 